Analyst Recommendations

Raymond James analyst issues STRONG BUY recommendation for TPX on February 8, 2024 01:41AM ET. The previous analyst recommendation was Strong Buy.TPX was trading at $51.25 at issue...

February 8, 2024   

Morgan Stanley analyst issues OVERWEIGHT recommendation for NVDA on February 7, 2024 02:10PM ET. The previous analyst recommendation was Overweight.NVDA was trading at $694.6728 at issue of the...

February 7, 2024   NVDA -0.44%

Bank of America Securities analyst issues BUY recommendation for LLY on February 7, 2024 02:49PM ET. The previous analyst recommendation was Buy.LLY was trading at $729.7 at issue...

February 7, 2024   LLY 0.53%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for CMG on February 7, 2024 01:25PM ET. The previous analyst recommendation was Equal-Weight.CMG was trading at $2713.26 at issue of the...

February 7, 2024   CMG -0.64%

RBC Capital analyst issues BUY recommendation for J on February 7, 2024 01:00PM ET. The previous analyst recommendation was Buy.J was trading at $143.03 at issue of the...

February 7, 2024   J -1.10%

Oppenheimer analyst issues OVERWEIGHT recommendation for MSFT on February 7, 2024 01:40PM ET. The previous analyst recommendation was Outperform.MSFT was trading at $412.955 at issue of the analyst...

February 7, 2024   MSFT 0.70%

Wedbush analyst issues OUTPERFORM recommendation for FTNT on February 7, 2024 11:39AM ET. The previous analyst recommendation was Outperform.FTNT was trading at $68.9737 at issue of the analyst...

February 7, 2024   FTNT -1.01%

Wedbush analyst issues OUTPERFORM recommendation for FTNT on February 7, 2024 11:39AM ET. The previous analyst recommendation was Outperform.FTNT was trading at $68.9737 at issue of the analyst...

February 7, 2024   FTNT -1.01%

Piper Sandler analyst issues NEUTRAL recommendation for FTNT on February 7, 2024 11:39AM ET. The previous analyst recommendation was Neutral.FTNT was trading at $68.9737 at issue of the...

February 7, 2024   FTNT -1.01%

Telsey Advisory analyst issues OUTPERFORM recommendation for COST on February 6, 2024 07:54AM ET. The previous analyst recommendation was Outperform.COST was trading at $711.16 at issue of the...

February 6, 2024   COST 0.72%